549
Views
12
CrossRef citations to date
0
Altmetric
Laboratory Studies

Angiotensin II-mediated activation of fibrotic pathways through ERK1/2 in rat peritoneal mesothelial cells

, , &
Pages 871-879 | Received 06 Apr 2010, Accepted 11 May 2010, Published online: 21 Jul 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Fang Sun, Zhigang Zhao, Qiang Li, Xunmei Zhou, Yingsha Li, Hexuan Zhang, Zhencheng Yan, Hongbo He, Zhigang Ke, Yu Gao, Fan Li, Weidong Tong & Zhiming Zhu. (2020) Detrimental Effect of C-Reactive Protein on the Cardiometabolic Cells and Its Rectifying by Metabolic Surgery in Obese Diabetic Patients. Diabetes, Metabolic Syndrome and Obesity 13, pages 1349-1358.
Read now

Articles from other publishers (11)

Sarah E. Herrick & Bettina Wilm. (2021) Post-Surgical Peritoneal Scarring and Key Molecular Mechanisms. Biomolecules 11:5, pages 692.
Crossref
Mahmood Tavakkoli, Saeed Aali, Borzoo Khaledifar, Gordon A. Ferns, Majid Khazaei, Kiavash Fekri & Mohammad-Hassan Arjmand. (2021) The Potential Association between the Risk of Post-Surgical Adhesion and the Activated Local Angiotensin II Type 1 Receptors: Need for Novel Treatment Strategies. Gastrointestinal Tumors 8:3, pages 107-114.
Crossref
Wenqin Zhang, Xin Li & Yun Zhang. (2019) Rho-kinase inhibitor attenuates airway mucus hypersecretion and inflammation partly by downregulation of IL-13 and the JNK1/2-AP1 signaling pathway. Biochemical and Biophysical Research Communications 516:2, pages 571-577.
Crossref
Ye Hongwei, Cao Ruiping, Fang Yingyan, Zhang Guanjun, Hu Jie, Liu Xingyu, Tang Jie, Li Zhenghong, Gao Qin, Hu Junfeng & Zhang Heng. (2019) Effect of Irbesartan on AGEs-RAGE and MMPs systems in rat type 2 diabetes myocardial-fibrosis model. Experimental Biology and Medicine 244:7, pages 612-620.
Crossref
Jun-Ting Liou, Chin-Sheng Lin, Yu-Cheng Liao, Ling-Jun Ho, Shih-Ping Yang & Jenn-Haung Lai. (2017) JNK/AP-1 activation contributes to tetrandrine resistance in T-cell acute lymphoblastic leukaemia. Acta Pharmacologica Sinica 38:8, pages 1171-1183.
Crossref
Ingrid Lua, Yuchang Li, Lamioko S. Pappoe & Kinji Asahina. (2015) Myofibroblastic Conversion and Regeneration of Mesothelial Cells in Peritoneal and Liver Fibrosis. The American Journal of Pathology 185:12, pages 3258-3273.
Crossref
Xuesong Su, Rui Yu, Xu Yang, Guangyu Zhou, Yanqiu Wang, Li Li & Detian Li. (2015) Telmisartan attenuates peritoneal fibrosis via peroxisome proliferator‐activated receptor‐ γ activation in rats . Clinical and Experimental Pharmacology and Physiology 42:6, pages 671-679.
Crossref
Chung-Jen Lee, Yi-Maun Subeq, Ru-Ping Lee, Hung-Hsiang Liou & Bang-Gee Hsu. (2014) Calcitriol decreases TGF-β1 and angiotensin II production and protects against chlorhexide digluconate-induced liver peritoneal fibrosis in rats. Cytokine 65:1, pages 105-118.
Crossref
Susan Yung, Na Jiang & Tak Mao Chan. (2013) Peritoneal fibrosis and the putative role of decorin. Hong Kong Journal of Nephrology 15:2, pages 55-61.
Crossref
Li Li, Dong Fan, Cheng Wang, Jin-Yu Wang, Xiao-Bing Cui, Dan Wu, Yun Zhou & Li-Ling Wu. (2011) Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-β1 pathways in cardiac fibroblasts. Cardiovascular Research 91:1, pages 80-89.
Crossref
Tyesha N. BurksEva Andres-MateosRuth MarxRebeca MejiasChristel Van ErpJessica L. SimmersJeremy D. WalstonChristopher W. WardRonald D. Cohn. (2011) Losartan Restores Skeletal Muscle Remodeling and Protects Against Disuse Atrophy in Sarcopenia. Science Translational Medicine 3:82.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.